Downregulation of S100A9 Reverses Cisplatin-Resistance and Inhibits Proliferation and Migration in Hypopharyngeal Carcinoma

Figure 2

Analysis of differential expression proteins in FaDu and FaDu/DDP. (a) GO analysis of DEPs. Top 10 enriched terms in BP, CC, and MF with a value less than 0.05. (b) KEGG pathway analysis of DEPs enriched the top 15 pathways with a value less than 0.05. (c) The PPI network among 30 differentially expressed cisplatin-resistance-related proteins.

(a)

(b)

(c)